
Explore microbial communities in uranium-contaminated subsurface at Oak Ridge, examining long-term effects of mixed-waste contamination and potential remediation strategies through cultivation-based and molecular analyses.

Explore a multi-omic AI platform combining tumor and host data to predict disease survival outcomes using advanced biomarker panels and machine learning techniques.

Explore CETSA's role in target engagement and mode of action deconvolution, focusing on cell background impact and mass spectrometry coupling for small compound analysis.

Explore advancements in mass spectrometry-based single-cell proteomics, focusing on improved sensitivity and measurement throughput using isotopic and isobaric labeling techniques.

Explore how real-time biological data can enhance cell-based cancer immunotherapy research, addressing challenges in experimental throughput and linking multi-modal data to individual cells.

Explore Bruker's Beacon® Optofluidic System for comprehensive single-cell analysis, enabling serial multi-modal examination and real-time imaging to accelerate antibody discovery and cell therapy development.

Explore advanced human antibody discovery techniques using Beacon system and Harbour Mice® technology. Learn about single B cell cloning, NGS integration, and in-chip assays for efficient screening and diverse antibody development.

Explore innovative RNA immunization and single-cell screening approaches to accelerate antibody discovery against challenging targets, enhancing diversity and efficiency in therapeutic development.

Explore genetically modified cell models for drug discovery, focusing on protein stabilization and DUBTAC approaches. Learn how engineered cell lines accelerate therapeutic development and enable disease modeling.

Explore genetic engineering tools for non-conventional yeast, focusing on microorganisms' role in circular processes and their potential for complex product conversion.

Explore adeno-associated virus (AAV) capsids for gene therapy, focusing on less-studied variants with potential benefits in potency, tissue tropism, and reduced immunogenicity.

Explore the potential of iNKT cells in developing allogeneic cancer immunotherapy. Learn about their unique properties and advantages in creating scalable, off-the-shelf cell products for cancer treatment.

Explore SLEEK, an efficient transgene knock-in technology for clinically relevant cell types. Learn about this CRISPR-based method for improved gene editing and its potential impact on cell-based medicines.

Explore development and verification processes for analytical platforms in cellular and gene therapy, focusing on key challenges and innovative solutions.

Explore cutting-edge techniques to enhance T cell immunotherapy production efficiency, from initial processing to final product manufacturing.

Explore implementing CGP and HRD testing in healthcare, covering technical aspects, concordance with other assays, and benefits of in-house testing for matching patients with therapies.

Explore cutting-edge genomic technologies for liquid biopsy in cancer research, focusing on minimally invasive approaches to analyze biomarkers in blood samples.

Explore blood culture reporting's role in improving diagnostics. Learn from Dr. Nicole Hubbard about specimen collection, laboratory quality, and diagnostic stewardship in clinical pathology.

Explore case studies addressing challenges in bacterial identification and antimicrobial susceptibility testing through expert insights on breakpoints and testing complexities.

Discover the features and benefits of VITEK® MS PRIME, the latest innovation in MALDI-TOF technology for clinical diagnostics.

Gain a clinician's perspective on updating breakpoints in antimicrobial susceptibility testing. Explore considerations, methods, and benefits for improving patient care and antibiotic stewardship.